News From The Web

NHS replaces highest-spend drug with £300m cheaper alternative

The NHS is set to make a record-breaking saving after reaching deals with manufacturers on low-cost “biosimilar” versions of its most expensive drug, according to the health service’s chief executive in England.

The deal should save hospitals £300m, which equates to roughly three-quarters of the amount they currently spend, Simon Stevens will announce on Monday.

The saving is the result of the introduction of drugs almost identical to adalimumab, which is prescribed to more than 46,000 patients to treat conditions such as rheumatoid arthritis, inflammatory bowel disease and psoriasis.

Read more in The Guardian.

Bookmark and Share

Post a Comment

Enter this security code

Submit Comment for Moderation